NCT06456801

Brief Summary

Conduct comparative experimental studies on clinical serum samples using assessment reagents and approved products, and evaluate the equivalence between assessment reagents and comparison reagents.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
219

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

June 7, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
Last Updated

June 13, 2024

Status Verified

June 1, 2024

Enrollment Period

7 months

First QC Date

June 7, 2024

Last Update Submit

June 7, 2024

Conditions

Nephropathy

Outcome Measures

Primary Outcomes (1)

  • Calculate the correlation between the test reagents and comparison reagents

    Calculate the correlation between the test reagents and comparison reagents

    1 year.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Chronic kidney disease

You may qualify if:

  • Clear background information and traceable sources of samples from kidney disease patients (number, age, gender, and clinical diagnostic information).

You may not qualify if:

  • Exclude serum samples that meet one of the following conditions:
  • ① Samples with insufficient sample size, ② Samples with incomplete sample information.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated hospital Zhejiang University school of medicine

Hangzhou, Zhejiang, 310001, China

Location

MeSH Terms

Conditions

Kidney Diseases

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Xiaoying Du

    Zhejiang University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of nephrology

Study Record Dates

First Submitted

June 7, 2024

First Posted

June 13, 2024

Study Start

March 1, 2021

Primary Completion

October 1, 2021

Study Completion

October 1, 2021

Last Updated

June 13, 2024

Record last verified: 2024-06

Locations

CN(1)